SEARCH
In-depth

This section will feature stories organised under individual categories, providing a resource for in-depth study of particular topics. It will get richer as more stories are added to the website.

Browse topics
economy, business and finance »  chemicals »  biotechnology
Filter by
Latest From This Topic
BERLIN, Friday, December 5, 2014

German regulator puts GVK Bio under lens

Clinical trial results of generic drugs questioned »
More on biotechnology AND: pharmaceutical
NEW DELHI, Tuesday, December 2, 2014

Ranbaxy launches arthritis drug Infimab

Ranbaxy Laboratories on Monday launched the first biosimilar version of Johnson and Johnson’s Remicade, a drug used for treating various conditions including rheumatoid arthritis. Infimab... »
More on biotechnology AND: business (general)pharmaceutical
Neemrana (Rajasthan), Saturday, November 16, 2013

Indian biotech aiming to be $100-bn sector by 2025: Shaw

Indian biotechnology sector is looking to be a $100 billion sector by 2025, Biocon Chief Kiran Mazumdar-Shaw said on Saturday. “We want to make Indian biotechnology a $100 billion sector... »
More on biotechnology AND: institutionmacro economics
Pages: «  1  »
Pages: «  1  »
More Articles about:  biotechnology
Browse topics